Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston
boston blog main
boston top stories
drugs
life sciences
national blog main
aminolevulinic acid
clinical trials
fda
givosiran
onpattro
patisiran
rna interference
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
european medicines agency
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
national top stories
new york blog main
new york top stories
paul matteis
pfizer
san diego blog main
san diego top stories
stifel financial
tafamidis
What
drug
4
×
medicine
4
×
rna
4
×
alnylam
interference
rnai
fda
new
pharmaceuticals
second
seek
speedy
ago
agriculture
alphafold
approval
approves
cells
cleared
data
deepmind
deepmind’s
development
discoveries
dna
ema
employ
europe
far
follows
gene
google
harmful
help
hits
illustration
improved
indicated
introducing
life’s
Language
unset
Current search:
rna
×
medicine
×
drug
×
@theverge.com
29 days ago
Google DeepMind’s new AI can model DNA, RNA, and ‘all life’s molecules’
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
